Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 2.64%92.6M | 38.70%164.81M | 55.99%90.22M | -20.65%118.83M | -40.78%57.83M | -45.23%19.84M | -12.21%149.75M | -2.65%122.09M | 7.28%97.66M | 26.97%36.23M |
| Operating income | 2.64%92.6M | 38.70%164.81M | 55.99%90.22M | -20.65%118.83M | -40.78%57.83M | -45.23%19.84M | -12.21%149.75M | -2.65%122.09M | 7.28%97.66M | 26.97%36.23M |
| Cost of sales | -3.44%-71.88M | -38.57%-126.94M | -58.00%-69.49M | 21.80%-91.6M | 43.04%-43.98M | 48.87%-15.08M | 14.15%-117.13M | 5.22%-95.44M | -2.43%-77.22M | -26.88%-29.49M |
| Operating expenses | -3.44%-71.88M | -38.57%-126.94M | -58.00%-69.49M | 21.80%-91.6M | 43.04%-43.98M | 48.87%-15.08M | 14.15%-117.13M | 5.22%-95.44M | -2.43%-77.22M | -26.88%-29.49M |
| Gross profit | -0.05%20.71M | 39.12%37.88M | 49.63%20.72M | -16.51%27.23M | -32.25%13.85M | -29.34%4.77M | -4.45%32.61M | 7.86%26.65M | 30.61%20.44M | 27.38%6.75M |
| Selling expenses | 18.56%-4.54M | -30.52%-12.96M | -15.04%-5.58M | 1.17%-9.93M | 0.80%-4.85M | 3.54%-2.34M | -28.49%-10.05M | -27.38%-7.21M | -31.34%-4.89M | -28.47%-2.43M |
| Administrative expenses | 17.79%-11.08M | 6.86%-24.02M | -3.74%-13.47M | -18.78%-25.78M | -27.06%-12.99M | -19.89%-6.19M | 1.45%-21.71M | 4.10%-15.44M | 10.11%-10.22M | 7.72%-5.16M |
| Special items of operating profit | -143.08%-383K | 109.97%774K | 127.45%889K | -41.11%-7.76M | -2,391.54%-3.24M | -106.78%-67K | -135.82%-5.5M | -91.73%1.27M | -131.25%-130K | 1.86%988K |
| Operating profit | 83.88%4.71M | 110.29%1.67M | 135.47%2.56M | -249.81%-16.25M | -238.82%-7.22M | -2,799.30%-3.83M | -123.66%-4.65M | -71.24%5.26M | 433.20%5.2M | 111.64%142K |
| Financing cost | 47.71%-342K | 0.00%-1.15M | -25.53%-654K | -282.06%-1.15M | -280.29%-521K | -207.59%-243K | 62.19%-301K | 79.77%-195K | 78.18%-137K | 76.20%-79K |
| Earning before tax | 128.98%4.37M | 103.01%523K | 124.64%1.91M | -251.77%-17.4M | -252.85%-7.75M | -6,569.84%-4.08M | -126.25%-4.95M | -70.77%5.07M | 1,356.03%5.07M | 104.06%63K |
| Tax | ---- | 141.12%81K | 118.64%269K | -2,362.50%-197K | -11,200.00%-1.44M | -2,516.13%-811K | -102.16%-8K | -106.15%-20K | -92.61%13K | -123.31%-31K |
| After-tax profit from continuing operations | 100.69%4.37M | 103.43%604K | 123.69%2.18M | -255.18%-17.6M | -280.87%-9.19M | -15,371.88%-4.89M | -125.79%-4.96M | -71.42%5.05M | 869.47%5.08M | 102.26%32K |
| Earning after tax | 100.69%4.37M | 103.43%604K | 123.69%2.18M | -255.18%-17.6M | -280.87%-9.19M | -15,371.88%-4.89M | -125.79%-4.96M | -71.42%5.05M | 869.47%5.08M | 102.26%32K |
| Profit attributable to shareholders | 100.69%4.37M | 103.43%604K | 123.69%2.18M | -255.18%-17.6M | -280.87%-9.19M | -15,371.88%-4.89M | -125.79%-4.96M | -71.42%5.05M | 869.47%5.08M | 102.26%32K |
| Basic earnings per share | 150.00%0.01 | 103.41%0.0015 | 117.39%0.004 | -254.84%-0.044 | -276.92%-0.023 | -12,300.00%-0.0122 | -125.83%-0.0124 | -70.45%0.013 | 1,200.00%0.013 | 102.86%0.0001 |
| Diluted earnings per share | 150.00%0.01 | 103.41%0.0015 | 117.39%0.004 | -254.84%-0.044 | -276.92%-0.023 | -12,300.00%-0.0122 | -125.83%-0.0124 | -70.45%0.013 | 1,200.00%0.013 | 102.86%0.0001 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | -- | National Health Accounting Firm Co., Ltd. | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.